Roche's Avastin helps colorectal cancer patients
Key points
- Patients with advanced colorectal cancer who received Roche's Avastin live longer when they also receive the drug as part of their second round of treatment, the Swiss drugmaker said on Thursday, citing a late-stage study.
- Patients with metastatic colorectal cancer first treated with Avastin and standard chemotherapy before being given Avastin with a different chemotherapy after their disease had progressed lived significantly longer than those given only chemotherapy in the second-line setting, Roche said.
- The news is likely to boost sentiment around the drug, which recently suffered a major setback when U.S. authorities decided to revoke their backing of its use in breast cancer.
- Roche will submit the results of the ML 18147 study at an upcoming medical meeting.
Patients with advanced colorectal cancer who received Roche's Avastin live longer when they also receive the drug as part of their second round of treatment, the Swiss drugmaker said on Thursday, citing a late-stage study.
Patients with metastatic colorectal cancer first treated with Avastin and standard chemotherapy before being given Avastin with a different chemotherapy after their disease had progressed lived significantly longer than those given only chemotherapy in the second-line setting, Roche said.
The news is likely to boost sentiment around the drug, which recently suffered a major setback when U.S. authorities decided to revoke their backing of its use in breast cancer.
Roche will submit the results of the ML 18147 study at an upcoming medical meeting.
In Europe, Avastin is currently approved in colorectal, lung, renal, breast cancer and it has just won approval in ovarian cancer.
###
(Reuters)
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsIncidence of colorectal cancer increasing in young adults
The incidence of colorectal cancer (CRC) among young adults ages 20-39 years has increased during the past 20-30 years, despite declining rates of CRC for the U.S. population overall. This surprising new finding, an…
23 January 2015
NewsSemen Test for Prostate Cancer Helps Diagnose Early Warning Signs
A new diagnostic test that analyzes samples of seminal fluid could help detect early signs of prostate cancer, according to a study published in the journal Endocrine-Related Cancer. As the current PSA (prostate…
10 June 2014
NewsScreening has prevented half a million colorectal cancers
An estimated half a million cancers were prevented by colorectal cancer screening in the United States from 1976 to 2009, report researchers from the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER)…
3 June 2014
